|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Gains (losses) on digital assets | |||||
| Operating costs and expenses: | |||||
| Cost of revenues | |||||
| General and administrative | |||||
| Operations, research and development | |||||
| Sales and marketing | |||||
| Loss on impairment of finite-lived intangible assets | |||||
| Loss on impairment of property and equipment | |||||
| Total operating expenses | |||||
| Total operating (loss) | |||||
| Other income | |||||
| Other expense | |||||
| Gain (loss) on derivative instruments | |||||
| Benefit from release of valuation allowance | |||||
| Loss from continuing operations | |||||
| Loss from discontinued operations | |||||
| Net loss | |||||
| Loss from continuing operations (in dollars per share) | |||||
| Loss from discontinued operations (in dollars per share) | |||||
| Net loss per common share, basic and diluted (in dollars per share) | |||||
| Weighted average shares used in computation – basic and diluted (in shares) | |||||
Loading...